Protective Effect of Lycium Barbarum Polysaccharides on Anti-Tuberculosis Drug-Induced Injury to Human Hepatocytes and Its Mechanism

Jianteng Wei,Yongsheng Li,Han Wang,Dong Pei,Ningli Wang,Duolong Di,Yewei Liu
DOI: https://doi.org/10.21203/rs.3.rs-698780/v1
2021-01-01
Abstract:Abstract Studies have shown that Lycium barbarum polysaccharides (LBPs) have a protective effect on liver injury, but the mechanism is not fully understood. In this work, the effect of LBPs on L-02 cells exposed to anti-tuberculosis drug was investigated and the potential molecular mechanism was explored. Results showed that LBPs significantly prevented anti-tuberculosis drug-induced hepatotoxicity in a dose-dependent manner, as indicated by cell viability and diagnostic indicators of liver injury. The anti-tuberculosis drug promoted the production of reactive oxygen species and enhanced the oxidative stress, as evidenced by an increase in the malondialdehyde level and a decrease in the antioxidant enzyme levels in the liver. These effects were suppressed by treatment with LBPs. Furthermore, exploration of the underlying mechanism of LBPs revealed that the caspase-3 activity was markedly inhibited by the treatment with LBPs in the liver of anti-tuberculosis drug-treated mice. LBPs increased the expression level of Nrf2, thereby inactivating proapoptotic signaling events and restoring the balance between proapoptotic Bax and antiapoptotic Bcl-2 proteins in the cell of anti-tuberculosis drug-treated mice. In conclusion, LBPs inhibited anti-tuberculosis drug-induced apoptosis partly due to its antioxidant and antiapoptosis activities via the Nrf2 signaling pathway.
What problem does this paper attempt to address?